MetLife (MET) Projected to Post Earnings on Wednesday

MetLife (NYSE:MET) is expected to be announcing its Q4 2025 results after the market closes on Wednesday, February 4th. Analysts expect MetLife to post earnings of $2.38 per share and revenue of $31.4313 billion for the quarter. Individuals can find conference call details on the company’s upcoming Q4 2025 earning report page for the latest details on the call scheduled for Thursday, February 5, 2026 at 9:00 AM ET.

MetLife (NYSE:MET) last announced its quarterly earnings results on Wednesday, November 5th. The financial services provider reported $2.37 EPS for the quarter, beating analysts’ consensus estimates of $2.30 by $0.07. The firm had revenue of $12.46 billion during the quarter, compared to analysts’ expectations of $18.64 billion. MetLife had a net margin of 5.30% and a return on equity of 21.00%. The company’s revenue for the quarter was down 5.9% compared to the same quarter last year. During the same quarter last year, the company posted $1.95 earnings per share. On average, analysts expect MetLife to post $10 EPS for the current fiscal year and $11 EPS for the next fiscal year.

MetLife Stock Down 0.6%

MetLife stock opened at $76.73 on Wednesday. The company has a debt-to-equity ratio of 0.54, a current ratio of 0.18 and a quick ratio of 0.18. The company’s 50-day moving average is $78.57 and its 200-day moving average is $78.81. The firm has a market capitalization of $50.56 billion, a PE ratio of 14.45, a P/E/G ratio of 0.73 and a beta of 0.76. MetLife has a fifty-two week low of $65.21 and a fifty-two week high of $87.93.

MetLife Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 10th. Shareholders of record on Tuesday, February 3rd will be given a dividend of $0.5675 per share. This represents a $2.27 dividend on an annualized basis and a yield of 3.0%. The ex-dividend date of this dividend is Tuesday, February 3rd. MetLife’s payout ratio is 42.75%.

Hedge Funds Weigh In On MetLife

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Clark Capital Management Group Inc. increased its position in shares of MetLife by 4.8% in the third quarter. Clark Capital Management Group Inc. now owns 3,175 shares of the financial services provider’s stock worth $262,000 after purchasing an additional 145 shares during the period. Tocqueville Asset Management L.P. lifted its holdings in shares of MetLife by 0.6% during the 3rd quarter. Tocqueville Asset Management L.P. now owns 26,071 shares of the financial services provider’s stock worth $2,147,000 after acquiring an additional 156 shares during the period. Triumph Capital Management boosted its position in shares of MetLife by 4.8% during the 3rd quarter. Triumph Capital Management now owns 3,570 shares of the financial services provider’s stock worth $294,000 after acquiring an additional 164 shares in the last quarter. Nicolet Advisory Services LLC increased its stake in MetLife by 4.2% in the third quarter. Nicolet Advisory Services LLC now owns 4,719 shares of the financial services provider’s stock valued at $391,000 after acquiring an additional 190 shares during the last quarter. Finally, Evergreen Capital Management LLC raised its position in MetLife by 2.0% during the second quarter. Evergreen Capital Management LLC now owns 10,726 shares of the financial services provider’s stock valued at $863,000 after purchasing an additional 214 shares in the last quarter. 94.99% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

MET has been the subject of several research analyst reports. Keefe, Bruyette & Woods reduced their target price on MetLife from $92.00 to $90.00 and set an “outperform” rating for the company in a research note on Tuesday, November 11th. Morgan Stanley set a $101.00 price objective on shares of MetLife and gave the stock an “overweight” rating in a research report on Monday, December 15th. Mizuho set a $102.00 price objective on shares of MetLife in a research report on Wednesday, January 14th. Evercore ISI set a $97.00 target price on shares of MetLife and gave the stock an “in-line” rating in a report on Tuesday, January 6th. Finally, Wells Fargo & Company increased their price target on shares of MetLife from $94.00 to $97.00 and gave the company an “overweight” rating in a report on Tuesday, January 13th. Two investment analysts have rated the stock with a Strong Buy rating, nine have issued a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat, MetLife presently has an average rating of “Buy” and an average target price of $95.27.

About MetLife

MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.

In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.